Epigenetic regulation during mammalian oogenesis
John Bromfield A B , Will Messamore A B and David F. Albertini A B C DA Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
B The Center for Reproductive Sciences, University of Kansas Medical Center, Kansas City, KS 66160, USA.
C Marine Biological Laboratory, Woods Hole, MA 02543, USA.
D Corresponding author. Email: dalbertini@kumc.edu
Reproduction, Fertility and Development 20(1) 74-80 https://doi.org/10.1071/RD07181
Published: 12 December 2007
Abstract
The advent of the epigenetic era has sparked a new frontier in molecular research and the understanding of how development can be regulated beyond direct alterations of the genome. Thus far, the focal point of epigenetic regulation during development has been chromatin modifications that control differential gene expression by DNA methylation and histone alterations. But what of events that alter gene expression without direct influence on the DNA itself? The present review focuses on epigenetic pathways regulating development from oogenesis to organogenesis and back that do not involve methylation of cytosine in DNA. We discuss target components of epigenetic modification such as organelle development, compartmentalisation of maternal factors and molecular mediators in the oocyte and how these factors acting during oogenesis impact on later development. Epigenetic regulation of development, be it via cytosine methylation or not, has wide-ranging effects on the subsequent success of a pregnancy and the intrinsic health of offspring. Perturbations in epigenetic regulation have been clearly associated with disease states in adult offspring, including Type II diabetes, hypertension, cancers and infertility. A clear understanding of all epigenetic mechanisms is paramount when considering the increased use of assisted reproductive techniques and the risks associated with their use.
Additional keywords: assisted reproductive technique, developmental programming, embryogenesis, methylation.
Acknowledgements
The authors thank members of the Albertini laboratory for their support and advice and recognise the National Institutes of Health (HD42076), ESHE Fund and the Hall Family Foundation for their generous support.
Albertini, D. F. , and Carabatsos, M. J. (1998). Comparative aspects of meiotic cell cycle control in mammals. J. Mol. Med. 76, 795–799.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
Burns, K. H. , Viveiros, M. M. , Ren, Y. , Wang, P. , DeMayo, F. J. , Frail, D. E. , Eppig, J. J. , and Matzuk, M. M. (2003). Roles of NPM2 in chromatin and nucleolar organization in oocytes and embryos. Science 300, 633–636.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
Young, L. E. , Fernandes, K. , McEvoy, T. G. , Butterwith, S. C. , Gutierrez, C. G. , Carolan, C. , Broadbent, P. J. , Robinson, J. J. , Wilmut, I. , and Sinclair, K. D. (2001). Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat. Genet. 27, 153–154.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
Yuba-Kubo, A. , Kubo, A. , Hata, M. , and Tsukita, S. (2005). Gene knockout analysis of two gamma-tubulin isoforms in mice. Dev. Biol. 282, 361–373.
| Crossref | GoogleScholarGoogle Scholar | PubMed |